Navigation Links
Indiana Biopharmaceutical Service Providers Maintain Steady Growth Despite Industry Challenges
Date:2/10/2010

INDIANAPOLIS, Feb. 10 /PRNewswire/ -- Indiana's contract pharmaceutical research and manufacturing companies continued to expand in 2009, despite challenges in the biopharmaceutical contract service sector due to the downturn in the economy, the prospect of healthcare reform and other market developments.  New service providers were established, facility expansions were announced, and service line extensions were added by companies such as AIT Laboratories, BioConvergence, BioStorage Technologies and Covance.

In an updated survey on biopharmaceutical market developments, Industry Developments in U.S. Biopharmaceutical Contract Services, BioCrossroads highlights evolving trends in the contract service sector, including the industry-wide drive for pharmaceutical and biotechnology companies to lower costs, access specialized services and increase flexibility through outsourcing work to contract service providers (CSPs). This new report supplements the major sector study prepared by BioCrossroads in 2008, Biopharma Discovery and Development Contract Services – Indiana Market Opportunities and Funding Options.

"We believe the outlook for the biopharma contract service sector continues to be positive, particularly for Indiana's pharmaceutical development and contract manufacturing companies," said David Johnson, president and CEO of BioCrossroads, Indiana's public-private collaboration for investment, development and advancement of the state's signature life sciences strengths. "The emergence of fully integrated pharmaceutical networks (FIPNETs) has changed the landscape and accelerated the pace of pharmaceutical product development. The trend of outsourcing that we predicted in our 2008 BioCrossroads study is now standard practice for bringing a product to market in this industry."

The new report acknowledges that while 2009 was slow for many CSPs, the underlying reasons for pharmaceutical and biotechnology companies to outsource selected activities will continue for the foreseeable future.  CSPs should continue to grow as the pharmaceutical industry moves towards a more flexible business model. Biomarker services and the need for larger clinical trials will provide opportunities for additional growth in future years.   However, with the consolidation of the pharmaceutical industry and the continued trend of strategic partnerships between CSPs and their clients, many companies in the sector will be drawn to find new revenue sources.  

"Outsourcing to contract organizations helps reduce the high costs and long lead times of product development while minimizing scientific and business risks," said Alisa Wright, president and CEO of Bloomington, IN-based BioConvergence. "Because of the growing needs for specific development functions that our pharmaceutical clients requested, we added service lines in 2009, including collection kit production and  biorepository capacity.  We plan to expand our services further in 2010."

With nearly 9,000 workers and more than 40 companies working in the CSP sector, Indiana is a national center for biopharma development and manufacturing.  The state is one of only a few regions in the United States with a concentration of companies that excel in specialized and sophisticated drug development services such as contract research, contract manufacturing, and logistics.  BioCrossroadsLINX was established in 2007 to develop and strengthen these Indiana drug development and manufacturing capabilities through educational and workforce development programs and regional collaborations.

The full report is available at www.biocrossroads.com and www.biocrossroadslinx.com

About BioCrossroads

BioCrossroads (www.biocrossroads.com) is Indiana's initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region's existing research and corporate strengths while encouraging new business development.  BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, and Datalys Center), expands collaboration and partnerships among Indiana's life science institutions, promotes science education and markets Indiana's life sciences industry. 

SOURCE BioCrossroads

RELATED LINKS
http://www.biocrossroads.com

'/>"/>

SOURCE BioCrossroads
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Indiana Industry, University and Community Leaders Capitalize on Next Generation of States Life Sciences Growth
2. Collaboration of Indianas Health Information Exchanges, State Organizations Submits Application for Health Information Technology Stimulus Funding
3. A New Economic Future for Rural Indiana?: Study to Show How Renewable Energy Could Trigger Boom for Economically Struggling Areas in State
4. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
5. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
6. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
7. Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy
8. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
9. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
10. SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
11. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
Breaking Biology Technology:
(Date:6/9/2016)... TURKU, Finland , June 9, 2016 ... French National Police deploy Teleste,s video security solution to ensure ... France during the major tournament ... and data communications systems and services, announced today that its ... Police Prefecture to back up public safety across ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, ... Infrastructure, Support & Other Service  The latest ... comprehensive analysis of the global Border Security market ... of $17.98 billion in 2016. Now: In ... in software and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
Breaking Biology News(10 mins):